Search
ATR-04
go.drugbank.com/drugs/DB26782InvestigationalATR-04 is a biologic drug. ATR-04 is under investigation in clinical trial NCT04731259 (Study to Evaluate the Safety of ATR-04).
Oremepermin alfa
go.drugbank.com/drugs/DB27148InvestigationalOremepermin alfa is a recombinant human hepatocyte growth factor (isoform 3) and glycoprotein composed of an α-chain and a β-chain.[L54006] It is produced in CHO cells.[L54006]
HNF4α srRNA
go.drugbank.com/drugs/DB27228InvestigationalHNF4α srRNA is a biologic drug. … HNF4α srRNA is under investigation in clinical trial NCT06583993 (A Clinical Trial Evaluating the Safety and Efficacy of Intravenous HNF4α srRNA in Treating Advanced ICC Patients).
AEF0117
go.drugbank.com/drugs/DB27675InvestigationalAEF0117 is a small molecule drug. AEF0117 is under investigation in clinical trial NCT05554926 (Study of [4-14C] AEF0117 Following a Single Oral Dose in Healthy Male Subjects).
Synonyms: 3ß-(4-methoxybenzyloxy)pregn-5-en-20-one, 3β-(4-methoxybenzyloxy)pregn-5-en-20-oneNGM707
go.drugbank.com/drugs/DB28351InvestigationalNGM707 is a humanized IgG antibody with specificity for both LILRB1 and LILRB2.
H-151
go.drugbank.com/drugs/DB29149ExperimentalH-151 is an inhibitor of the stimulator of interferon genes (STING) protein.
Synonyms: 1-(4-Ethylphenyl)-3-(1H-indol-3-yl) urea, N-(4-ethylphenyl)-N'-1H-indol-3-yl-ureaTovecimig
go.drugbank.com/drugs/DB30220InvestigationalNOV1501 is a biologic drug. … NOV1501 is under investigation in clinical trial NCT03292783 (This is a Study to Evaluate the Safety and Tolerability of the Study Drug ABL001, and to Determine the Maximum Tolerated Dose and/or Recommended
Categories: Heterocyclic Compounds, 1-RingLutetium (177Lu) NeoB
go.drugbank.com/drugs/DB30389InvestigationalLutetium (177Lu) NeoB is a biologic drug.
Synonyms: Lu-NeoB, [177Lu]Lu-NeoBARI-0001
go.drugbank.com/drugs/DB30635InvestigationalARI-0001 is a biologic drug. ARI-0001 is under investigation in clinical trial NCT05641428 (Comparison of Point-of-care Produced CAR T-cell with Commercial CAR T-cells in Patients with R/R LBCL).